The Intersection of Regulatory and Patent Exclusivities for the Life Sciences Industry: A Comparative Overview of American and European Schemes

An article written by Jonathan Roses and Toby Simpson, partner at Hoffmann Eitle, titled “The intersection of regulatory and patent exclusivities for the life sciences industry: a comparative overview of American and European schemes” was published in The Pharma Letter. Read more (subscription required).

This article is the first in a series exploring legal issues relevant to the life sciences industry and how they vary between the two major jurisdictions of the United States and Europe. The other articles included in this series are: 

• Double Patenting in the USA and Europe
• Salt and Solid Form Issues in US and European Patents
• Doctrine of Equivalents in US and European Patent Law